Table 1 Serum and CSF Electrophoresis and GAD65 Antibody Titers
From: A case of stiff dog syndrome associated with anti-glutamic acid decarboxylase antibodies
Sample | Total Protein (g/dl) | Albumin (%) | Globulins (%) | Anti-GAD65 Antibody Titer (IU/ml) | |||
|---|---|---|---|---|---|---|---|
α - 1 | α - 2 | β | γ | ||||
Negative Control Canine Seruma | 6.9 ± 1.0 | 44.7 ± 3.9 | 11.3 ± 2.4 | 14.9 ± 3.1 | 21.6 ± 3.5 | 8.5 ± 1.0 | 8.0 ± 1.2 |
SDS Canine Serum Day 1 | 8.1 | 37.1 | 8.2 | 12.2 | 17.8 | 24.7 | 348 ± 25.1 |
SDS Canine Serum Day 6 | 7.4 | 41.2 | 8.4 | 11.6 | 19.5 | 19.3 | 77 ± 9.5 |
SDS Canine Serum Day 25 | 7.5 | NA | NA | NA | NA | NA | 106 ± 17.1 |
SDS Canine Serum Day 100 | 7.8 | NA | NA | NA | NA | NA | 46 ± 13.1 |
Human AntiGAD-65 Ab Positive Serum | 7.2 | NA | NA | NA | NA | NA | 38 ± 8.5 |
Control CSFa | 0.018 ± 2.4 | 39.7 ± 3.5 | 11.3 ± 1.5 | 15.8 ± 1.7 | 20.6 ± 3.3 | 7.6 ± 1.2 | ND |
SDS Canine CSF Day 1 | 0.1 | NA | NA | NA | NA | NA | NA |
SDS Patient CSF Day 6 | 0.025 | 39.2 | 8.5 | 14.6 | 18.2 | 19.5 | 54 ± 8.0 |